Valion Bio, Inc. Common Stock (VBIO) Expected to Post Earnings on Monday

Valion Bio, Inc. Common Stock (NASDAQ:VBIO) will likely be posting its Q2 2026 resultson Monday, August 17th. Analysts expect Valion Bio, Inc. Common Stock to announce earnings of ($408.00) per share and revenue of $0.46 million for the quarter. Investors may visit the the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 20, 2026 at 4:30 PM ET.

Valion Bio, Inc. Common Stock (NASDAQ:VBIO) last posted its quarterly earnings data on Thursday, May 14th. The company reported ($2.23) earnings per share (EPS) for the quarter.

Valion Bio, Inc. Common Stock Price Performance

VBIO stock opened at $0.29 on Monday. The company has a current ratio of 3.31, a quick ratio of 3.02 and a debt-to-equity ratio of 0.62. Valion Bio, Inc. Common Stock has a one year low of $0.25 and a one year high of $5.60. The firm has a market capitalization of $1.18 million, a PE ratio of -0.04 and a beta of 1.85. The firm has a 50-day moving average of $0.49 and a two-hundred day moving average of $0.81.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Valion Bio, Inc. Common Stock in a report on Friday, July 17th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.

Valion Bio, Inc. Common Stock Company Profile

Tivic Health Systems is a commercial-stage medical technology company that develops and markets non-drug, neuromodulation-based therapies for nasal and sinus health. The company’s solutions are designed to alleviate sinus pain, pressure and congestion through gentle microcurrent and vibration stimulation. By targeting the underlying nerve pathways in the nasal passages, Tivic Health aims to provide an alternative to over-the-counter and prescription medications without introducing systemic side effects.

The flagship product, ClearUP™ Sinus Pain Relief, is an FDA-cleared, hand-held device intended for home use.